A Scientia Advisors study suggests that neurostimulation technologies have fewer side effects and could help cut health care costs by doing away with the need for lifelong drug regimens.
The MLSC, charged with distributing some $1B over a ten year period, invested $48.5 M in public dollars this year–its first full year of operation. The funds, in turn, have attracted nearly $359M in matching investments from companies, foundations, government, institutes and other private investors–an eight-fold return.
In a recent talk, MIT Institute Professor Bob Langer described the difficulties he faced in his early career. For job hunters out there the message is simple but profound. Believe in yourself and your ideas, treat people kindly, and keep on going.
Great talk, Bob. Once again, bravo.
ScientiaNET, Scientia Advisors’ new knowledge network, now 10 thousand strong, is accepting new member/experts and clients for life science consultation, surveys, and opinions.
Scientia Advisors is offering five free Webinars for anyone interested in trends in the health care and life science industries.